Abeona Therapeutics’ (ABEO) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright restated their buy rating on shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) in a report released on Monday morning, Marketbeat.com reports. The firm currently has a $15.00 price target on the biopharmaceutical company’s stock. A number of other equities analysts have also recently commented on ABEO. StockNews.com cut shares of Abeona Therapeutics […]
HC Wainwright restated their buy rating on shares of Abeona Therapeutics (NASDAQ:ABEO – Free Report) in a report released on Monday morning, Marketbeat.com reports. The firm currently has a $15.00 price target on the biopharmaceutical company’s stock. A number of other equities analysts have also recently commented on ABEO. StockNews.com cut shares of Abeona Therapeutics […]
